PIOMBINO DESE, Italy-- (BUSINESS WIRE)--Mar 12, 2026-- ...

Vertex's CF drugs are bringing in billions of dollars in revenue, and in recent years the company has also expanded into ...

Foreign facilities failed FDA GMP inspections at up to 1.8x the U.S. rate. Journal of Pharmaceutical Innovation study ...

F rom blockbuster drugs that garner media attention to smaller innovations that help millions maintain health, the biotech and pharmaceutical industries have an impact on everyone’s life. Meanwhile, ...

KALA BIO (KALA) stock soared 70% pre-market after revealing plans to launch its first commercial AI agent in 14 days through ...

Xenon Pharmaceuticals said its treatment for a common type of seizure disorder significantly reduced the frequency of those seizures compared to a placebo.

In an effort to battle against what members feel is an existential threat to their businesses, a group of 10 domestic biotech companies has launched the Midsized Biotech Alliance of America (MBAA) ...

X4 Pharmaceuticals is a BUY, driven by a funded Phase 3 trial, current product pipeline, and a strong cash position extending ...

Everyone should save money for retirement, since programs such as Social Security aren't meant to replace workers' entire ...

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

Learn more about whether Catalyst Pharmaceuticals, Inc. or Xenon Pharmaceuticals Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

North Carolina, ranked in the top five states for life sciences by Business Facilities, is home to a thriving ecosystem specializing in bio and pharmaceutical manufacturing. Propelled by a low cost of ...